Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Sanjiu Medical Kicks Off Industrial Park Operation

This article was originally published in PharmAsia News

Executive Summary

With the backing of main shareholder China Resources Enterprise, restructured Sanjiu Medical & Pharmaceutical has finished constructing its industrial park and begun operations. The 300-million-yuan phase one project, located in the city's Guanlan High Tech Area, occupies 110,000 square meters. Sanjiu will acquire another 70,000 square meters for phase two, earmarked for related pharmaceutical production and auxiliary facilities. According to CR Enterprise, Sanjiu will focus on OTC brands as its core business, with TCM prescription and free-decocting TCM as fast-growth areas. The firm will reorganize its antibiotics and generics business to enter the tier-three end-user market. The latest event marks a key milestone for CR Enterprise, which will base its pharmaceutical headquarters in Shenzhen to further boost the business. (Click here for more - Chinese Language)



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts